Cambridge UK: 22 June 2026
Kadans Science Partner has become a Corporate Sponsor of One Nucleus. The One Nucleus Corporate Sponsor Programme is tailor-made to meet the needs of One Nucleus Members, the Sponsor and One Nucleus in delivering on its core remit of supporting innovation.
Katie Nelson, Head of Leasing UK&I at Kadans Science Partner commented:
‘We are delighted to be working with One Nucleus, expanding our reach across leading life science communities and ecosystems. Their commitment to fostering interdisciplinary connectivity not only…
Tony JonesCEO, One Nucleus
The Heat is ON in 2026Many have always claimed that there has been no shortage of hot air around when it comes to discussing developments in biotech. The growing sense of optimism perhaps is a reflection of investment heating up in drug discovery, China’s growing impact on the sector’s dynamics, new initiatives and some very large exits all adding up to a sense of dynamism and optimism, but perhaps some pragmatism still when many attended the BIO Convention in San Diego.
Venture Investment in Drug Discovery in Q2 2026Reviewing…
The Francis Crick Institute and Medicines Discovery Catapult (MDC) have today opened applications for the ninth cohort of KQ Labs, a national accelerator for data-driven health start-ups.
Delivered by the Francis Crick Institute, with ongoing support from MDC and Cancer Research Horizons, KQ Labs is an annual five-month programme for early-stage companies building science-backed, scalable solutions in AI-driven drug discovery, digital health, and precision medicine.
Up to ten high-potential companies will receive weekly workshops, expert mentoring, office hours with leading pharmaceutical…
EcoVadis rating validates Boyds’ business sustainability commitments and performance.
Global drug development consultancy, Boyds is pleased to announce that it has achieved a Bronze Medal from EcoVadis, a global leader in business sustainability assessments.
In the company’s latest rating, which was completed in April 2026, Boyds scored 65 out of 100, which places Boyds in the top 35% of companies globally.
Commenting on the achievement, Boyds’ CEO, Professor Alan Boyd MBE said: “Achieving an EcoVadis Bronze Medal is an important milestone for Boyds and reflects the commitment we have made…
MDC welcomes new Chair from January 2027 to drive impact as next-generation technologies and collaborations reshape drug discovery
Medicines Discovery Catapult (MDC) is delighted to announce today the selection of its next Chair of the Board. Professor Sir Mike Ferguson will take up the position from the beginning of 2027, succeeding Dr Robin Brown, who expertly led the organisation as Chair for nine years.
A transition period will follow, with Robin vacating the post at the end of December this year, having completed his valuable service to the Catapult. MDC is deeply grateful for the…
BioInnovation Institute (BII), a leading institute for life science and deep tech start-ups, has chosen Victoria House in London as the location for its UK base – the first research space outside of its headquarters in Copenhagen - marking a major milestone in BII’s expansion of translational innovation across Europe.
The London hub, which was developed by Pioneer Group and Oxford Properties, will serve as the flagship site for BII’s newly launched CardioMetabolic Bridge initiative - a pan-European effort backed by the Novo Nordisk Foundation and designed to accelerate the translation of…
Johnson & Johnson’s corporate venture capital organization, Johnson & Johnson Innovation – JJDC, Inc. (“JJDC”), and BGF join existing investors Cambridge Innovation Capital, DDF, M Ventures, Pfizer Ventures, Eli Lilly and Company, MP Healthcare Venture Management (MPH), Cambridge Enterprise Ventures
Cambridge, UK, 23 June 2026: TRIMTECH Therapeutics (TRIMTECH or the Company), a biotechnology company developing novel small molecule therapies that target and degrade protein aggregates associated with neurodegenerative diseases, today announced it has raised an additional $14 million in…
LONDON, UK, ZUG, Switzerland and STOCKHOLM, Sweden – June 23, 2026 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully led a search for Cellcolabs and is pleased to announce the placement of Vincent Metzler, Ph.D., as Chief Executive Officer (CEO). Cellcolabs is a Swedish biotechnology company specializing in the large-scale, industrial production of high-quality mesenchymal stromal cells (MSCs) to prevent and treat debilitating and life-threatening diseases.Dr. Metzler joins the company at a critical…
The Awards are taking place on 10 December 2026 at 1 Wimpole Street, London, UK at the Genesis conference!
The One Nucleus Awards has been integrated into the Genesis Conference, to recognise outstanding achievements across our ecosystem. All shortlisted companies will receive a free delegate pass and will be invited to pitch at the company showcase, plus having the opportunity to network with over 400 delegates.
Combining the annual Genesis Conference and Annual Awards celebration provides Life Science innovators, companies and their support ecosystem with the opportunity to connect,…
More than 1,600 local students from 49 schools across east Kent have taken part in the region’s largest ever science jamboree.
The annual two-day event, held at Discovery Park in Sandwich, transformed the science and business park into a hub of exploration and hands-on learning, bringing together young people, businesses and universities to learn about the world of science, technology, engineering and mathematics (STEM).
Organised by STEM Hub at Canterbury Christ Church University, the jamboree delivers a range of exciting practical scientific experiments and activities for the students to…